Asian press release distribution

Press Releases for Wednesday, November 30, 2022

	IBO Technology Announces 2022 Interim Results 23:01 HKT/SGT

	Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index 22:43 HKT/SGT

	JE Cleantech (JCSE) Announces Strong Growth in Q3 2022 22:30 HKT/SGT

	SCIB Posts 14.5% Increase in Revenue to RM30.3 Million in 1Q FY2023 20:00 HKT/SGT

	Yew Lee Posts RM6.1 Million Revenue in 3Q 20:00 HKT/SGT

	'Balance Beyond the Boom' - HKTDC Entrepreneur Day helps start-ups prepare for the post-pandemic landscape 19:00 HKT/SGT

	AssetWise PCL (SET: ASW) continues partnership with Japan property giant Takara Leben 18:00 HKT/SGT

	MHI Publishes Integrated Report "MHI Report 2022" 17:07 HKT/SGT

	AEON Credit Secures its Framework for Sustainability-Linked Loans, Strengthens and Advances its Sustainability Pledge 16:30 HKT/SGT

	Mitsubishi Heavy Industries Engineering to be Integrated into MHI 15:02 HKT/SGT

	Strong profile bodes well for PRI's entry on the MAI (SET) today 15:00 HKT/SGT

	NEC Orchestrating Future Fund, an Ecosystem-type CVC Fund, Completes Final Close for US$140 Million 14:15 HKT/SGT

	Mitsubishi Power to Upgrade Two Gas Turbines at Tuas Power to Achieve 16.9 kilo-tonnes of Carbon Emissions Reduction Annually 13:55 HKT/SGT

	Titan Projects 10x Business Growth for 2022 Partnering with aCommerce in the Philippines 12:30 HKT/SGT

	Wintermar Offshore (WINS:JK) Acquires 2 Additional AHTS and Celebrates the 12th Anniversary of Listing on IDX 12:00 HKT/SGT

	Poh Heng Encapsulates Women Empowerment with its Latest Freestyle Collection 11:40 HKT/SGT

	Poh Heng Encapsulates Women Empowerment with its Latest Freestyle Collection 11:40 HKT/SGT

	ExxonMobil, Mitsubishi Heavy Industries Form Carbon Capture Technology Alliance 10:56 HKT/SGT

	Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease at Clinical Trials on Alzheimer's Disease (CTAD) Conference 09:21 HKT/SGT

	Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine 08:31 HKT/SGT

	D3eSports Announces REV3AL Partnership for Virtual-to-Real E-Racing Programs 01:20 HKT/SGT

ACN Search:

RSS

News Alerts


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Privacy Policy \| Terms of Use \| RSS

US: +1 214 890 4418 \| Beijing: +86 400 879 3881 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575

Connect With us: